Search

Your search keyword '"Humalog (Medication)"' showing total 651 results
Start Over Descriptor "Humalog (Medication)"
651 results on '"Humalog (Medication)"'

1. Eli Lilly Reports Temporary Shortage of Humalog and Insulin Lispro Injection

Subjects
Eli Lilly and Co., Type 1 diabetes, Insulin, Pharmaceutical industry, Insulin lispro, Product shortage, Health, Humalog (Medication)
Abstract

HealthDay News — Eli Lilly & Co. announced on Friday a temporary shortage of 2 of its insulin products. “The 10mL vials of https://www.empr.com/drug/humalog/ and Insulin Lispro Injection are or [...]

Published
2024

2. Patents and regulatory exclusivities on FDA-approved insulin products: A longitudinal database study, 1986-2019

Author

Olsen, Anders, Beall, Reed F., Knox, Ryan P., Tu, Sean S., Kesselheim, Aaron S., and Feldman, William B.

Subjects
United States. Food and Drug Administration, Eli Lilly and Co., Sanofi S.A., Diabetes therapy, Insulin glargine, Databases, Insulin, Patents, Type 2 diabetes, Patent/copyright issue, CD-ROM catalog, Database, CD-ROM database, Biological sciences, Basaglar (Medication), Humalog (Medication), Lantus (Medication)
Abstract

Background Insulin is the primary treatment for type 1 and some type 2 diabetes but remains costly in the United States, even though it was discovered more than a century ago. High prices can lead to nonadherence and are often sustained by patents and regulatory exclusivities that limit competition on brand-name products. We sought to examine how manufacturers have used patents and regulatory exclusivities on insulin products approved from 1986 to 2019 to extend periods of market exclusivity. Methods and findings We used the publicly available Food and Drug Administration (FDA) Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) to identify all approved biosynthetic insulin products. Individual products approved under the same New Drug Application (NDA)-e.g., a vial and pen-were considered as separate products for the purposes of analysis. We recorded all patents and regulatory exclusivities listed in the Orange Book on each product and used Google Patents to extract the timing of patent application and whether patents were obtained on delivery devices or others aspects of the product. The primary outcome was the duration of expected protection, which was determined by subtracting the FDA approval date for each product from its last-to-expire patent or regulatory exclusivity (whichever occurred later). We performed a secondary analysis that considered overall protection on insulin lines-defined as groups of products approved under the same NDA with the same active ingredients manufactured by the same company. We also examined competition from follow-on insulin products-defined as products approved with the same active ingredients as originators but manufactured by different companies (approved via a specific drug approval pathway under section 505(b)(2) of the Food, Drug, and Cosmetic Act). During the study period, the FDA approved 56 individual products across 25 different insulin lines and 5 follow-ons across 3 different insulin lines. Thirty-three (59%) of the 56 products were drug-device combinations. Manufacturers of 9 products approved during the study period obtained patents filed after FDA approval that extended their duration of expected protection (by a median of 6 years). Approximately 63% of all patents on drug-device combinations approved during the study period were related to delivery devices. The median duration of expected protection on insulin products was 16.0 years, and the median protection on insulin lines was 17.6 years. An important limitation of our analysis is that manufacturers may continue to add patents on existing insulin products while competitors may challenge patents; therefore, periods of protection may change over time. Conclusions Among several strategies that insulin manufacturers have employed to extend periods of market exclusivity on brand-name insulin products are filing patents after FDA approval and obtaining a large number of patents on delivery devices. Policy reforms are needed to promote timely competition in the pharmaceutical market and ensure that patients have access to low-cost drugs., Author(s): Anders Olsen 1,2, Reed F. Beall 1,3, Ryan P. Knox 1,4, Sean S. Tu 5, Aaron S. Kesselheim 1, William B. Feldman 1,6,* Introduction Insulin remains a central treatment [...]

Published
2023
Full Text
View/download PDF

3. JDRF STATEMENT AND UPDATE ON INSULIN SHORTAGE

Subjects
Eli Lilly and Co., Insulin, Pharmaceutical industry, Insulin lispro, Product shortage, News, opinion and commentary, NovoLog (Medication), Humalog (Medication)
Abstract

NEW YORK, NY -- The following information was released by the Juvenile Diabetes Research Foundation International (JDRF): JDRF is aware that, unfortunately, individuals are having trouble filling their prescriptions for [...]

Published
2024

4. 4 ENDOCRINE DISORDERS

Subjects
Merck & Company Inc., Pfizer Inc., AstraZeneca PLC, Novo Nordisk A/S, Ulcerative colitis, Lupus, Systemic lupus erythematosus, Antifungal agents, Prednisone, Pharmaceutical industry, Cortisone, Health, Humalog (Medication), Lyumjev (Medication), Glucophage (Medication)
Abstract

4A Corticosteroid-responsive disorders PRESCRIBING NOTES Corticosteroids are potent drugs that affect many organ systems. The doses of these drugs must be individualized. Corticosteroid-responsive conditions include: Adrenocortical insufficiency: Hydrocortisone, cortisone; prednisone [...]

Published
2021

5. Eli Lilly Warns That 2 Insulin Products Will Be in Short Supply

Subjects
Eli Lilly and Co., Insulin, Diabetics, Insulin lispro, Health, Humalog (Medication)
Abstract

Byline: Ernie Mundell and Carole Tanzer Miller HealthDay Reporters MONDAY, March 25, 2024 (HealthDay News) -- Drugmaker Eli Lilly & Co is announcing a temporary shortage of two of its [...]

Published
2024

6. Eli Lilly warns of temporary short supply of two insulin products

Subjects
Eli Lilly and Co., Insulin, Type 2 diabetes, Pharmaceutical industry, Insulin lispro, General interest, News, opinion and commentary, Humalog (Medication)
Abstract

Byline: Meg Tirrell, CNN (CNN) -- (CNN) — Drugmaker Eli Lilly warned this week that two of its formulations of insulin would be temporarily out of stock through the beginning [...]

Published
2024

7. Lilly Reports Strong Fourth Quarter 2023 Financial Results and Provides 2024 Guidance

Subjects
Eli Lilly and Co. -- Company sales and earnings, Pharmaceutical industry -- Company sales and earnings, Company earnings/profit, Business, Jardiance (Medication), Trulicity (Medication), Verzenio (Medication), Mounjaro (Medication), Taltz (Medication), Humalog (Medication), Zepbound (Medication)
Abstract

INDIANAPOLIS: Eli Lilly and Company (NYSE: LLY) today announced its financial results for the fourth quarter of 2023. '2023 was a year of tremendous achievement for Lilly, which delivered life-changing [...]

Published
2024

8. Lilly Reports Strong Fourth-Quarter 2023 Financial Results and Provides 2024 Guidance

Subjects
Eli Lilly and Co. -- Company sales and earnings, Pharmaceutical industry -- Company sales and earnings, Company earnings/profit, General interest, News, opinion and commentary, Jardiance (Medication), Trulicity (Medication), Verzenio (Medication), Mounjaro (Medication), Taltz (Medication), Humalog (Medication)
Abstract

INDIANAPOLIS: Eli Lilly and Company has issued the following news release: Eli Lilly and Company (NYSE: LLY) today announced its financial results for the fourth quarter of 2023. '2023 was [...]

Published
2024

9. 4 ENDOCRINE DISORDERS

Subjects
Merck & Company Inc., Pfizer Inc., AstraZeneca PLC, Novo Nordisk A/S, Ulcerative colitis, Lupus, Systemic lupus erythematosus, Antifungal agents, Prednisone, Pharmaceutical industry, Cortisone, Health, Humalog (Medication), Glucophage (Medication)
Abstract

4A Corticosteroidresponsive disorders PRESCRIBING NOTES Corticosteroids are potent drugs that affect many organ systems. The doses of these drugs must be individualized. Corticosteroid-responsive conditions include: Adrenocortical insufficiency: Hydrocortisone, cortisone; prednisone [...]

Published
2021

10. 4 ENDOCRINE DISORDERS

Subjects
Merck & Company Inc., Pfizer Inc., AstraZeneca PLC, Novo Nordisk A/S, Ulcerative colitis, Lupus, Systemic lupus erythematosus, Antifungal agents, Prednisone, Pharmaceutical industry, Cortisone, Health, Humalog (Medication), Glucophage (Medication)
Abstract

4A Corticosteroid-responsive disorders PRESCRIBING NOTES Corticosteroids are potent drugs that affect many organ systems. The doses of these drugs must be individualized. Corticosteroid-responsive conditions include: Adrenocortical insufficiency: Hydrocortisone, cortisone; prednisone [...]

Published
2021

11. 4 ENDOCRINE DISORDERS

Subjects
Merck & Company Inc., Pfizer Inc., AstraZeneca PLC, Novo Nordisk A/S, Ulcerative colitis, Lupus, Systemic lupus erythematosus, Antifungal agents, Prednisone, Pharmaceutical industry, Cortisone, Health, Humalog (Medication), Glucophage (Medication)
Abstract

4A Corticosteroid-responsive disorders PRESCRIBING NOTES Corticosteroids are potent drugs that affect many organ systems. The doses of these drugs must be individualized. Corticosteroid-responsive conditions include: Adrenocortical insufficiency: Hydrocortisone, cortisone; prednisone [...]

Published
2020

12. 4 ENDOCRINE DISORDERS

Subjects
Merck & Company Inc., Pfizer Inc., AstraZeneca PLC, Novo Nordisk A/S, Lupus, Systemic lupus erythematosus, Prednisone, Ulcerative colitis, Cobicistat, Cortisone, Antifungal agents, Pharmaceutical industry, Health, Humalog (Medication), Glucophage (Medication)
Abstract

4A Corticosteroid-responsive disorders PRESCRIBING NOTES Corticosteroids are potent drugs that affect many organ systems. The doses of these drugs must be individualized. Corti-costeroid-responsive conditions include: Adrenocortical insufficiency: Hydrocortisone, cortisone; prednisone [...]

Published
2020

13. 4 ENDOCRINE DISORDERS

Subjects
Merck & Company Inc., Pfizer Inc., AstraZeneca PLC, Novo Nordisk A/S, Lupus, Systemic lupus erythematosus, Prednisone, Ulcerative colitis, Cobicistat, Cortisone, Antifungal agents, Pharmaceutical industry, Genetic disorders, Pemphigus, Addison's disease, Enteritis, Myocarditis, Hemolytic anemia, Thrombocytopenia, Corticosteroid drugs, Mycosis fungoides, Anemia, Collagen, Rhinitis, Tenosynovitis, Stevens-Johnson syndrome, Ankylosing spondylitis, Glucocorticoids, Asthma, Prednisolone, Hydrocortisone, Tennis elbow, Arthritis, Purpura, Lupus erythematosus, Bursitis, Colitis, Spondylitis, Thrombocytopenic purpura, Health, Humalog (Medication), Glucophage (Medication)
Abstract

4A Corticosteroid-responsive disorders PRESCRIBING NOTES Corticosteroids are potent drugs that affect many organ systems. The doses of these drugs must be individualized. Corti-costeroid-responsive conditions include: Adrenocortical insufficiency: Hydrocortisone, cortisone; prednisone [...]

Published
2020

14. 4 ENDOCRINE DISORDERS

Subjects
Merck & Company Inc., Pfizer Inc., AstraZeneca PLC, Novo Nordisk A/S, Lupus, Systemic lupus erythematosus, Prednisone, Ulcerative colitis, Cobicistat, Cortisone, Antifungal agents, Pharmaceutical industry, Genetic disorders, Pemphigus, Addison's disease, Enteritis, Myocarditis, Hemolytic anemia, Thrombocytopenia, Corticosteroid drugs, Mycosis fungoides, Anemia, Collagen, Rhinitis, Tenosynovitis, Stevens-Johnson syndrome, Ankylosing spondylitis, Glucocorticoids, Asthma, Prednisolone, Hydrocortisone, Tennis elbow, Arthritis, Purpura, Lupus erythematosus, Bursitis, Colitis, Spondylitis, Thrombocytopenic purpura, Health, Humalog (Medication), Glucophage (Medication)
Abstract

4A Corticosteroid-responsive disorder PRESCRIBING NOTES Corticosteroids are potent drugs that affect many organ systems. The doses of these drugs must be individualized. Corticosteroid-responsive conditions include: Adrenocortical insufficiency: Hydrocortisone, cortisone; prednisone [...]

Published
2020

15. Supply Of Inj Humalog Kwick Pen 100iu Per Ml Plain Each Ml Contain Insulin Lispro 3 5mg Lispro, Inj Rabipur, Isabgol Husk 3 5gm, Tab Levodopa 200mg Plus Carbidopa 50mg, Tab L Ornithine L Aspartate 150mg Pancreatin Hepalair 100mg - Drugs Pharmaceuticals

Subjects
Carbidopa, Insulin, Insulin lispro, Business, international, Humalog (Medication)
Abstract

Tenders are invited for Supply of Inj Humalog Kwick Pen 100IU per ml Plain Each ml contain Insulin lispro 3 5mg Lispro, Inj Rabipur, Isabgol husk 3 5gm, Tab Levodopa [...]

Published
2023

16. Supply Of Tab Carvedilol 6.25 Mg, Tab Chlorthalidone 6.25 Mg, Tab Clinidipine 5 Mg, Clinidpine 10 Mg Tab, Clopidogrel 75 Mg + Aspirin 75 Mg Tab, Clozapine 25 Mg Tab, Diltiazem 30 Mg Tab, Divalproex 250 Mg Tab, Eptus 25mg Tab (eplerenone), Escitalopram 10

Subjects
Perampanel, Neomycin, Trifluoperazine, Chlorthalidone, Lacosamide, Etoricoxib, Clozapine, Blood platelets -- Aggregation, Insulin lispro, Telmisartan, Business, international, Humalog (Medication)
Abstract

Tenders are invited for Supply of Tab Carvedilol 6.25 Mg, Tab Chlorthalidone 6.25 Mg, Tab Clinidipine 5 Mg, Clinidpine 10 Mg Tab, Clopidogrel 75 Mg + Aspirin 75 Mg Tab, [...]

Published
2023

18. Supply Of Cap Indomethacin 75mg, Tab Isosorbide Dinitrate 20mg Plus Hydralazine 37 5mg, Tab Isoniazid-300mg, Inj Diclofenac Sodium, Inj Dicyclomine 2ml, Inj Hydrocortisone, Inj Heparin Sodium 1000iu Ml 5ml, Inj Humalog Kwick Pen 100iu Ml Plain, Inj Methyl

Subjects
Heparin, Isosorbide dinitrate, Diabetes therapy, Dicyclomine, Lacosamide, Isoniazid, Hypoglycemic agents, Hydrocortisone, Indomethacin, Business, international, Humalog (Medication)
Abstract

Tenders are invited for Supply of Cap Indomethacin 75mg, Tab Isosorbide Dinitrate 20mg plus Hydralazine 37 5mg, Tab Isoniazid-300mg, Inj Diclofenac Sodium, Inj Dicyclomine 2ml, Inj Hydrocortisone, Inj Heparin sodium [...]

Published
2023

19. 4 ENDOCRINE DISORDERS

Subjects
Merck & Company Inc., Pfizer Inc., AstraZeneca PLC, Novo Nordisk A/S, Lupus, Systemic lupus erythematosus, Prednisone, Ulcerative colitis, Cobicistat, Cortisone, Antifungal agents, Pharmaceutical industry, Genetic disorders, Pemphigus, Addison's disease, Enteritis, Myocarditis, Hemolytic anemia, Thrombocytopenia, Corticosteroid drugs, Mycosis fungoides, Anemia, Collagen, Rhinitis, Tenosynovitis, Stevens-Johnson syndrome, Ankylosing spondylitis, Glucocorticoids, Asthma, Prednisolone, Hydrocortisone, Tennis elbow, Arthritis, Purpura, Lupus erythematosus, Bursitis, Colitis, Spondylitis, Thrombocytopenic purpura, Health, Humalog (Medication), Glucophage (Medication)
Abstract

4A Corticosteroidresponsive disorders PRESCRIBING NOTES Corticosteroids are potent drugs that affect many organ systems. The doses of these drugs must be individualized. Corticosteroid-responsive conditions include: Adrenocortical insufficiency: Hydrocortisone, cortisone; prednisone [...]

Published
2019

20. 4 ENDOCRINE DISORDERS

Subjects
Merck & Company Inc., Pfizer Inc., AstraZeneca PLC, Novo Nordisk A/S, Lupus, Systemic lupus erythematosus, Prednisone, Ulcerative colitis, Cobicistat, Cortisone, Antifungal agents, Pharmaceutical industry, Genetic disorders, Pemphigus, Addison's disease, Enteritis, Myocarditis, Hemolytic anemia, Thrombocytopenia, Corticosteroid drugs, Mycosis fungoides, Anemia, Collagen, Rhinitis, Tenosynovitis, Stevens-Johnson syndrome, Ankylosing spondylitis, Glucocorticoids, Asthma, Prednisolone, Hydrocortisone, Tennis elbow, Arthritis, Purpura, Lupus erythematosus, Bursitis, Colitis, Spondylitis, Thrombocytopenic purpura, Health, Humalog (Medication), Glucophage (Medication)
Abstract

4A Corticosteroid-responsive disorders PRESCRIBING NOTES Corticosteroids are potent drugs that affect many organ systems. The doses of these drugs must be individualized. Corticosteroid-responsive conditions include: Adrenocortical insufficiency: Hydrocortisone, cortisone; prednisone [...]

Published
2019

21. 4 ENDOCRINE DISORDERS

Subjects
Merck & Company Inc., Pfizer Inc., AstraZeneca PLC, Novo Nordisk A/S, Lupus, Systemic lupus erythematosus, Prednisone, Ulcerative colitis, Cobicistat, Cortisone, Antifungal agents, Pharmaceutical industry, Genetic disorders, Pemphigus, Addison's disease, Enteritis, Myocarditis, Hemolytic anemia, Thrombocytopenia, Corticosteroid drugs, Mycosis fungoides, Anemia, Collagen, Rhinitis, Tenosynovitis, Stevens-Johnson syndrome, Ankylosing spondylitis, Glucocorticoids, Asthma, Prednisolone, Hydrocortisone, Tennis elbow, Arthritis, Purpura, Lupus erythematosus, Bursitis, Colitis, Spondylitis, Thrombocytopenic purpura, Health, Humalog (Medication), Glucophage (Medication)
Abstract

4A Corticosteroid-resnsive disorders PRESCRIBING NOTES Corticosteroids are potent drugs that affect many organ systems. The doses of these drugs must be individualized. Corticosteroid-responsive conditions include: Adrenocortical insufficiency: Hydrocortisone, cortisone; prednisone [...]

Published
2019

22. 4 ENDOCRINE DISORDERS

Subjects
Merck & Company Inc., Pfizer Inc., AstraZeneca PLC, Novo Nordisk A/S, Lupus, Systemic lupus erythematosus, Prednisone, Ulcerative colitis, Cobicistat, Cortisone, Antifungal agents, Pharmaceutical industry, Genetic disorders, Pemphigus, Addison's disease, Enteritis, Myocarditis, Hemolytic anemia, Thrombocytopenia, Corticosteroid drugs, Mycosis fungoides, Anemia, Collagen, Rhinitis, Tenosynovitis, Stevens-Johnson syndrome, Ankylosing spondylitis, Glucocorticoids, Asthma, Prednisolone, Hydrocortisone, Tennis elbow, Arthritis, Purpura, Lupus erythematosus, Bursitis, Colitis, Spondylitis, Thrombocytopenic purpura, Health, Humalog (Medication), Glucophage (Medication)
Abstract

4A Corticosteroid-responsive disorders PRESCRIBING NOTES Corticosteroids are potent drugs that affect many organ systems. The doses of these drugs must be individualized. Corticosteroid-responsive conditions include: Adrenocortical insufficiency: Hydrocortisone, cortisone; prednisone [...]

Published
2019

23. The Insulin Racket

Author

Shure, Natalie

Subjects
Eli Lilly and Co., Sanofi S.A., Type 2 diabetes, Diabetes therapy, Pharmaceutical industry, Insulin, Type 1 diabetes, Prescriptions (Drugs), Drugstores, Drugs, Hypoglycemic agents, Business, general, Humalog (Medication)
Abstract

Insulin is a 100-year-old drug whose wholesale price has tripled in ten years. The reasons why explain everything wrong with America's broken prescription drug market. On June 22,2017, Alec Raeshawn [...]

Published
2019

24. 4 ENDOCRINE DISORDERS

Subjects
Merck & Company Inc., Pfizer Inc., AstraZeneca PLC, Lupus, Systemic lupus erythematosus, Prednisone, Ulcerative colitis, Cortisone, Antifungal agents, Pharmaceutical industry, Genetic disorders, Pemphigus, Addison's disease, Enteritis, Myocarditis, Hemolytic anemia, Thrombocytopenia, Corticosteroid drugs, Mycosis fungoides, Anemia, Collagen, Rhinitis, Tenosynovitis, Stevens-Johnson syndrome, Ankylosing spondylitis, Glucocorticoids, Asthma, Prednisolone, Hydrocortisone, Tennis elbow, Arthritis, Purpura, Lupus erythematosus, Bursitis, Colitis, Spondylitis, Thrombocytopenic purpura, Health, Humalog (Medication), Glucophage (Medication)
Abstract

4A Corticosteroid-responsive disorders PRESCRIBING NOTES Corticosteroids are potent drugs that affect many organ systems. The doses of these drugs must be individualized. Corticosteroid-responsive conditions include: Adrenocortical insufficiency: Hydrocortisone, cortisone; prednisone [...]

Published
2019

25. 4 ENDOCRINE DISORDERS

Subjects
Merck & Company Inc., AstraZeneca PLC, Pfizer Inc., Pharmaceutical industry, Ulcerative colitis, Lupus, Antifungal agents, Cortisone, Systemic lupus erythematosus, Prednisone, Tenosynovitis, Addison's disease, Pemphigus, Prednisolone, Hemolytic anemia, Spondylitis, Arthritis, Lupus erythematosus, Stevens-Johnson syndrome, Thrombocytopenia, Mycosis fungoides, Purpura, Rhinitis, Anemia, Corticosteroid drugs, Thrombocytopenic purpura, Asthma, Ankylosing spondylitis, Bursitis, Tennis elbow, Glucocorticoids, Enteritis, Genetic disorders, Collagen, Hydrocortisone, Myocarditis, Colitis, Steroids (Organic compounds), Health, Glucophage (Medication), Humalog (Medication)
Abstract

4A Corticosteroid-responsive disorders PRESCRIBING NOTES Corticosteroids are potent drugs that affect many organ systems. The doses of these drugs must be individualized. Corticosteroid-responsive conditions include: Adrenocortical insufficiency: Hydrocortisone, cortisone; prednisone [...]

Published
2019

26. 4 ENDOCRINE DISORDERS

Subjects
Merck & Company Inc., AstraZeneca PLC, Pfizer Inc., Pharmaceutical industry, Ulcerative colitis, Lupus, Antifungal agents, Cortisone, Systemic lupus erythematosus, Prednisone, Tenosynovitis, Addison's disease, Pemphigus, Prednisolone, Hemolytic anemia, Spondylitis, Arthritis, Lupus erythematosus, Stevens-Johnson syndrome, Mycosis fungoides, Thrombocytopenia, Purpura, Rhinitis, Anemia, Corticosteroid drugs, Thrombocytopenic purpura, Asthma, Ankylosing spondylitis, Bursitis, Tennis elbow, Glucocorticoids, Enteritis, Genetic disorders, Collagen, Hydrocortisone, Myocarditis, Steroids (Organic compounds), Colitis, Health, Glucophage (Medication), Humalog (Medication)
Abstract

4A Corticosteroid-responsive disorders PRESCRIBING NOTES Corticosteroids are potent drugs that affect many organ systems. The doses of these drugs must be individualized. Corticosteroid-responsive conditions include: Adrenocortical insufficiency: Hydrocortisone, cortisone; prednisone [...]

Published
2019

27. 4 ENDOCRINE DISORDERS

Subjects
Merck & Company Inc., AstraZeneca PLC, Pfizer Inc., Pharmaceutical industry, Ulcerative colitis, Lupus, Antifungal agents, Cortisone, Systemic lupus erythematosus, Prednisone, Tenosynovitis, Addison's disease, Pemphigus, Prednisolone, Hemolytic anemia, Spondylitis, Arthritis, Lupus erythematosus, Stevens-Johnson syndrome, Thrombocytopenia, Mycosis fungoides, Purpura, Rhinitis, Anemia, Corticosteroid drugs, Thrombocytopenic purpura, Asthma, Ankylosing spondylitis, Bursitis, Tennis elbow, Glucocorticoids, Enteritis, Genetic disorders, Collagen, Hydrocortisone, Myocarditis, Steroids (Organic compounds), Colitis, Health, Glucophage (Medication), Humalog (Medication)
Abstract

4A Corticosteroid-responsive disorders PRESCRIBING NOTES Corticosteroids are potent drugs that affect many organ systems. The doses of these drugs must be individualized. Corticosteroid-responsive conditions include: Adrenocortical insufficiency: Hydrocortisone, cortisone; prednisone [...]

Published
2019

28. 4 ENDOCRINE DISORDERS

Subjects
Merck & Company Inc., AstraZeneca PLC, Pfizer Inc., Pharmaceutical industry, Ulcerative colitis, Lupus, Antifungal agents, Cortisone, Systemic lupus erythematosus, Prednisone, Tenosynovitis, Addison's disease, Pemphigus, Prednisolone, Hemolytic anemia, Spondylitis, Arthritis, Lupus erythematosus, Stevens-Johnson syndrome, Thrombocytopenia, Mycosis fungoides, Purpura, Rhinitis, Anemia, Corticosteroid drugs, Thrombocytopenic purpura, Asthma, Ankylosing spondylitis, Bursitis, Tennis elbow, Glucocorticoids, Enteritis, Genetic disorders, Collagen, Hydrocortisone, Myocarditis, Steroids (Organic compounds), Colitis, Health, Glucophage (Medication), Humalog (Medication)
Abstract

4A Corticosteroid-responsive disorderPRESCRIBING NOTESCorticosteroids are potent drugs that affect many organ systems. The doses of these drugs must be individualized. Corticosteroid-responsive conditions include:Adrenocortical insufficiency:Hydrocortisone, cortisone; prednisone or prednisolone (with mineralocorticoid).Rheumatic [...]

Published
2019

29. Eli Lilly Says It Will Cut the Price of Insulin

Author

Robbins, Rebecca

Subjects
Eli Lilly and Co., Insulin, Blood sugar, Pharmaceutical industry, News, opinion and commentary, Humalog (Medication)
Abstract

The company also trumpeted an existing policy that caps monthly out-of-pocket cost for its lifesaving products at $35. The drugmaker Eli Lilly and Company https://investor.lilly.com/news-releases/news-release-details/lilly-cuts-insulin-prices-70-and-caps-patient-insulin-out-pocket on Wednesday that it would [...]

Published
2023

31. Supply Of 14 Types Of Various Medicines At Bhel Sbd. Humalog Mix 50 100 Iu(3ml), Eyemist Eye Drops, Iotim Eye Drops, Brinolar Eye Drops, Newtel Am, Isryl M1 Tab, Nefrozen Caps, Glimaday Hs, Soframycin 30 Gms Tube, Rosys 5 Mg, Encorate Chrono 200, En

Subjects
Bharat Heavy Electricals Ltd., Ophthalmic drugs, Hypoglycemic agents, Electrical equipment and supplies industry, Business, international, Humalog (Medication)
Abstract

Tenders are invited for Supply of 14 Types of Various Medicines at BHEL SBD. Humalog Mix 50 100 Iu(3ml), Eyemist Eye Drops, Iotim Eye Drops, Brinolar Eye Drops, Newtel Am, [...]

Published
2023

32. Supply Of Insulin Lispro 100 Iu ( Humalog 100iu Cartridge)

Subjects
Insulin, Insulin lispro, Business, international, Humalog (Medication)
Abstract

Tenders are invited for Supply of Insulin Lispro 100 IU ( Humalog 100IU Cartridge). Tender Category : Goods OpeningDate : Jun 7 2023 12:00AM Major organization : Mormugao Port Trust [...]

Published
2023

33. Supply Of Endo Med Items - Libre Freestyle Glucose Monitoring Sensor, Insulin Premixed Biphasic 100 Iu Per Ml (50% Insulin Lispro + 50% Insulin Lispro Protamine), 3 Ml Per Cart|pfp, Humalog Mix 50|50), Disposable For Insulin Pump (quickset & Reservoir 10

Subjects
Fenofibrate, Corticosteroids, Dextrose, Cabergoline, Sensors, Hypoglycemic agents, Patient monitoring equipment, Glucose, Reservoirs, Ethinyl estradiol, Weight reducing preparations, Blood sugar monitoring, Business, international, Humalog (Medication)
Abstract

Tenders are invited for Supply of Endo Med Items - Libre Freestyle Glucose Monitoring Sensor, Insulin premixed biphasic 100 IU per ml (50% insulin lispro + 50% insulin lispro protamine), [...]

Published
2023

34. Insulin accessibility

Subjects
Eli Lilly and Co., Insulin, Type 2 diabetes, Pharmaceutical industry, News, opinion and commentary, Sports and fitness, Humalog (Medication)
Abstract

Humulin is one of Eli Lilly's most common synthesized insulin products. Photo by Lauren Gdowski. ZOE MILLER | STAFF REPORTER | zjmiller@butler.edu Eli Lilly and Company recently announced that the [...]

Published
2023

35. Eli Lilly reports Q3 Humalog sales $626.7M, down 5%

Subjects
Eli Lilly and Co. -- Company sales and earnings, Foreign exchange, Pharmaceutical industry -- Company sales and earnings, Company earnings/profit, Business, News, opinion and commentary, Humalog (Medication)
Abstract

The company said, 'For the third quarter of 2021, worldwide Humalog revenue decreased 5 percent compared with the third quarter of 2020, to $626.7 million. Revenue in the U.S. decreased [...]

Published
2021

36. Cipla to sell Lilly's Trulicity, Humalog diabetes treatments in India

Subjects
Eli Lilly and Co., Diabetes therapy, Hypoglycemic agents, Diabetics, Health, Trulicity (Medication), Humalog (Medication)
Abstract

Byline: admin On Monday, the companies said in a joint statement that India's Cipla (CIPL.NS) has signed a deal with Eli Lilly (LLY.N) to sell and distribute two of the [...]

Published
2021

37. Eli Lilly signs pact with Cipla to enhance access to Lilly's key diabetes products

Subjects
Cipla Ltd., Eli Lilly and Co., Pharmaceutical industry, Insulin lispro, Pharmaceuticals and cosmetics industries, Trulicity (Medication), Humalog (Medication)
Abstract

Byline: Our Bureau Eli Lilly and Company (India) Pvt. Ltd, a wholly owned subsidiary of Eli Lilly and Company, and Cipla Limited announced a strategic partnership in India to enhance [...]

Published
2021

38. 4 ENDOCRINE DISORDERS

Subjects
Merck & Company Inc., AstraZeneca PLC, Pfizer Inc., Pharmaceutical industry, Health, Glucophage (Medication), Humalog (Medication)
Abstract

4A Corticosteroid-responsive disordersPRESCRIBING NOTESCorticosteroids are potent drugs that affect many organ systems. The doses of these drugs must be individualized. Corticosteroid-responsive conditions include:Adrenocortical insufficiency:Hydrocortisone, cortisone; prednisone or prednisolone (with mineralocorticoid).Rheumatic [...]

Published
2018

39. 4 ENDOCRINE DISORDERS

Subjects
Merck & Company Inc., AstraZeneca PLC, Pfizer Inc., Pharmaceutical industry, Ulcerative colitis, Lupus, Antifungal agents, Cortisone, Systemic lupus erythematosus, Prednisone, Tenosynovitis, Addison's disease, Pemphigus, Prednisolone, Hemolytic anemia, Spondylitis, Arthritis, Lupus erythematosus, Stevens-Johnson syndrome, Mycosis fungoides, Thrombocytopenia, Purpura, Rhinitis, Anemia, Corticosteroid drugs, Thrombocytopenic purpura, Asthma, Ankylosing spondylitis, Bursitis, Tennis elbow, Glucocorticoids, Enteritis, Genetic disorders, Collagen, Hydrocortisone, Myocarditis, Steroids (Organic compounds), Colitis, Health, Glucophage (Medication), Humalog (Medication)
Abstract

4A Corticosteroid-responsive disordersPRESCRIBING NOTESCorticosteroids are potent drugs that affect many organ systems. The doses of these drugs must be individualized. Corticosteroid-responsive conditions include:Adrenocortical insufficiency:Hydrocortisone, cortisone; prednisone or prednisolone (with mineralocorticoid).Rheumatic [...]

Published
2018

40. 4 ENDOCRINE DISORDERS

Subjects
Merck & Company Inc., Pfizer Inc., AstraZeneca PLC, Lupus, Systemic lupus erythematosus, Prednisone, Ulcerative colitis, Cortisone, Antifungal agents, Pharmaceutical industry, Health, Humalog (Medication), Glucophage (Medication)
Abstract

4A Corticosteroid-responsive disorders PRESCRIBING NOTES Corticosteroids are potent drugs that affect many organ systems. The doses of these drugs must be individualized. Corti-costeroid-responsive conditions include: Adrenocortical insufficiency: Hydrocortisone, cortisone; prednisone [...]

Published
2018

41. 4 ENDOCRINE DISORDERS

Subjects
Merck & Company Inc., Pfizer Inc., AstraZeneca PLC, Sanofi S.A., Lupus, Systemic lupus erythematosus, Prednisone, Ulcerative colitis, Cortisone, Antifungal agents, Pharmaceutical industry, Health, Humalog (Medication), Glucophage (Medication)
Abstract

4A Corticosteroid-responsive disorders PRESCRIBING NOTES Corticosteroids are potent drugs that affect many organ systems. The doses of these drugs must be individualized. Corticosteroid-responsive conditions include: Adrenocortical insufficiency: Hydrocortisone, cortisone; prednisone [...]

Published
2018

42. 4 ENDOCRINE DISORDERS

Subjects
Merck & Company Inc., Pfizer Inc., AstraZeneca PLC, Sanofi S.A., Lupus, Systemic lupus erythematosus, Prednisone, Ulcerative colitis, Cortisone, Antifungal agents, Pharmaceutical industry, Health, Humalog (Medication), Glucophage (Medication)
Abstract

4A Corticosteroid-responsive disorders PRESCRIBING NOTES Corticosteroids are potent drugs that affect many organ systems. The doses of these drugs must be individualized. Corti-costeroid-responsive conditions include: Adrenocortical insufficiency: Hydrocortisone, cortisone; prednisone [...]

Published
2018

43. 4 ENDOCRINE DISORDERS

Subjects
Pfizer Inc., AstraZeneca PLC, Sanofi S.A., Lupus, Systemic lupus erythematosus, Prednisone, Ulcerative colitis, Cortisone, Antifungal agents, Pharmaceutical industry, Health, Humalog (Medication), Glucophage (Medication)
Abstract

4A Corticosteroidresponsive disorders PRESCRIBING NOTES Corticosteroids are potent drugs that affect many organ systems. The doses of these drugs must be individualized. Corticosteroid-responsive conditions include: Adrenocortical insufficiency: Hydrocortisone, cortisone; prednisone [...]

Published
2018

44. 4 ENDOCRINE DISORDERS

Subjects
Pfizer Inc., AstraZeneca PLC, Sanofi S.A., Lupus, Systemic lupus erythematosus, Prednisone, Ulcerative colitis, Cortisone, Antifungal agents, Pharmaceutical industry, Health, Humalog (Medication), Glucophage (Medication)
Abstract

4A Corticosteroid-responsive disorders PRESCRIBING NOTES Corticosteroids are potent drugs that affect many organ systems. The doses of these drugs must be individualized. Corticosteroid-responsive conditions include: Adrenocortical insufficiency: Hydrocortisone, cortisone; prednisone [...]

Published
2018

45. 4 ENDOCRINE DISORDERS

Subjects
Pfizer Inc., AstraZeneca PLC, Sanofi S.A., Lupus, Systemic lupus erythematosus, Prednisone, Ulcerative colitis, Cortisone, Antifungal agents, Pharmaceutical industry, Health, Humalog (Medication), Glucophage (Medication)
Abstract

4A Corticosteroidresponsive disorders PRESCRIBING NOTES Corticosteroids are potent drugs that affect many organ systems. The doses of these drugs must be individualized. Corti-costeroid-responsive conditions include: Adrenocortical insufficiency: Hydrocortisone, cortisone; prednisone [...]

Published
2018

46. 4 ENDOCRINE DISORDERS

Subjects
Pfizer Inc., AstraZeneca PLC, Sanofi S.A., Lupus, Systemic lupus erythematosus, Prednisone, Ulcerative colitis, Cortisone, Antifungal agents, Pharmaceutical industry, Health, Humalog (Medication), Glucophage (Medication)
Abstract

4A Corticosteroid-responsive disorders PRESCRIBING NOTES Corticosteroids are potent drugs that affect many organ systems. The doses of these drugs must be individualized. Corticosteroid-responsive conditions include: Adrenocortical insufficiency: Hydrocortisone, cortisone; prednisone [...]

Published
2018

47. 4 ENDOCRINE DISORDERS

Subjects
Pfizer Inc., AstraZeneca PLC, Sanofi S.A., Lupus, Systemic lupus erythematosus, Prednisone, Ulcerative colitis, Cortisone, Antifungal agents, Pharmaceutical industry, Health, Humalog (Medication), Glucophage (Medication)
Abstract

4A Corticosteroid-responsive disorders PRESCRIBING NOTES Corticosteroids are potent drugs that affect many organ systems. The doses of these drugs must be individualized. Corticosteroid-responsive conditions include: Adrenocortical insufficiency: Hydrocortisone, cortisone; prednisone [...]

Published
2018

48. Eli Lilly to lower list price of Insulin Lispro Injection by additional 40%

Subjects
Eli Lilly and Co., Insulin, Insulin lispro, Business, News, opinion and commentary, Humalog (Medication)
Abstract

Eli Lilly will lower the list price of Insulin Lispro Injection in the U.S. by an additional 40% effective January 1, 2022, effectively bringing the list price down to 2008 [...]

Published
2021

49. US FDA approves Lilly's insulin lispro-aabc injection, Lyumjev100 units/mL for use in insulin pumps

Subjects
United States. Food and Drug Administration, Eli Lilly and Co., Diabetes therapy, Insulin, Blood sugar, Type 2 diabetes, Diabetics, Pharmaceutical industry, Insulin lispro, Pharmaceuticals and cosmetics industries, Humalog (Medication), Lyumjev (Medication)
Abstract

The US Food and Drug Administration (FDA) has approved an expanded label for Eli Lilly and Company's rapid-acting insulin, Lyumjev (insulin lispro-aabc injection) 100 units/mL indicated to improve glycemic control [...]

Published
2021

50. Eli Lilly reports Q2 Humalog sales $607.6M, up 9%

Subjects
Eli Lilly and Co. -- Company sales and earnings, Foreign exchange, Pharmaceutical industry -- Company sales and earnings, Company earnings/profit, Business, News, opinion and commentary, Humalog (Medication)
Abstract

The company said, 'For the second quarter of 2021, worldwide Humalog revenue increased 9 percent compared with the second quarter of 2020, to $607.6 million. Revenue in the U.S. increased [...]

Published
2021

Catalog

Books, media, physical & digital resources
See catalog results